Journal of Bone and Mineral Research

Cover image for Vol. 29 Issue 9

Edited By: Juliet E Compston

Impact Factor: 6.589

ISI Journal Citation Reports © Ranking: 2013: 12/123 (Endocrinology & Metabolism)

Online ISSN: 1523-4681

Recently Published Issues

See all


virtual issue

For Authors

in memoriam

Updated Author Guidelines

•Abbreviations and acronyms section has been added along with a list of Standard JBMR® Abbreviations

•Additional nomenclature guidelines for papers on the descriptive epidemiology of osteoporosis

•Additional criterion for authorship in keeping with ICMJE update

New manuscripts are expected to comply by March 1, 2014

Click Here


Improve Your Chances of Getting Published at JBMR® Publications Workshop

Meet with JBMR® Editor-in-Chief Dr. Juliet Compston at this year’s Publications Workshop in Houston, Texas, USA. You’ll learn how to improve the quality of your journal manuscripts,what JBMR®is looking for and how to increase your chances of getting published. Wiley Senior Marketing Manager Larry Grodsky, Wiley Publisher Jinnie Kim, and Wiley Associate Editor Katie Simmons will also update you on maximizing visibility for your paper, navigating the submission process and timeline, and taking advantage of the latest technology. Whether you’re a new author considering submitting a paper or a seasoned journal contributor, don’t miss this unique opportunity to hear directly from and interact withJBMR®'s editor!

Publication Workshop

The Publications Workshop will be held Friday, Sept. 12, 2014, 9:30-11:00 a.m., at the George R. Brown Convention Center, Room 332D.

New Content

Subscribe to RSS headline updates from: Journal of Bone and Mineral Research
Powered by FeedBurner

Media Pickup

As seen in MD Linx

Bone mineral density changesaAmong women initiating proton pump inhibitors or H2 receptor antagonists: A SWAN Cohort Study

Click Here

Journal of Bone and Mineral Research, 08/25/2014 Clinical Article

Solomon DH, et al. – Proton pump inhibitors (PPIs) have been associated with diminished bone mineral density (BMD) and an increased risk of fracture, however prior studies have not yielded consistent results and many have sub–optimal ascertainment of both PPI use and BMD. BMD increased as expected in HT users, supporting the validity of the study design. These longitudinal analyses plus similar prior studies argue against an association between PPI use and BMD loss.

Abstract Here

As seen in MD Linx

Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women

Click Here

Journal of Bone and Mineral Research, 08/25/2014 Clinical Article

Reppe S, et al. – This study describes the epigenetic regulation of SOST expression in bone biopsies of postmenopausal women. The observations suggest that increased SOST promoter methylation seen in OP is a compensatory counteracting mechanism, which lowers serum sclerostin concentrations and reduces inhibition of Wnt signaling in an attempt to promote bone formation.

Abstract Here

As seen in MD Linx

Cortical thickness of the femur and long-term bisphosphonate use

Click Here

Journal of Bone and Mineral Research, 08/25/2014 Clinical Article

Niimi R, et al. – In this study, the authors aim was to investigate the relationship between cortical thickness and bisphosphonate (BP) use. The study did not find evidence of cortical thickening at the subtrochanteric/femoral shaft (ST/FS) area of the femur with long–term BP use.

Abstract Here